Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00148798
Status:
COMPLETED
Last Update Posted:
2014-06-25
First Post:
2005-09-07
Brief Title:
Study of CisplatinVinorelbine - Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer FLEX
Sponsor:
Organization:
Merck KGaA Darmstadt Germany